PROTECT-1: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function
This study has been completed.
Study NCT00328692
Information provided by NovaCardia
First Received: May 19, 2006
Last Updated: October 8, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study: